These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5605424)

  • 21. Role of vitamin D in pulmonary tuberculosis.
    Narang NK; Gupta RC; Jain MK
    J Assoc Physicians India; 1984 Feb; 32(2):185-8. PubMed ID: 6746514
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of pulmonary tuberculosis in patients with drug dependence].
    Zadremaĭlova TA; Aksenova KI
    Probl Tuberk Bolezn Legk; 2003; (7):31-3. PubMed ID: 12939874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of preparations of group B vitamins also at high dosage and by the parenteral route in a population of hospitalized patients].
    Paoletti V; Strazzera P; Katsarou V; Mammarella A; Barlattani M
    Acta Vitaminol Enzymol; 1984; 6(4):355-61. PubMed ID: 6534177
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical picture, course and therapeutic efficiency of pulmonary tuberculosis in patients with organochlorine pesticides and hepatitis B markers].
    Mukhtarov DZ
    Probl Tuberk; 1998; (5):23-4. PubMed ID: 9866392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of a combination of corticoids and vitamins with liver extract in adjuvant therapy of pulmonary tuberculosis].
    Mulargia A; Burnaccini P
    Minerva Med; 1969 May; 60(39):1902-8. PubMed ID: 5787473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effectiveness of chemotherapy in combination with electrophoresis and ultraviolet irradiation of blood in newly diagnosed patients with destructive pulmonary tuberculosis].
    Zhadnov VZ; Mishanov RF; Kuznetsov AA; Shprykov AS; Ryzhakova TM
    Probl Tuberk; 1995; (3):20-2. PubMed ID: 7617626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of decaris in the complex treatment of destructive pulmonary tuberculosis].
    German AK; Logiĭko VL
    Vrach Delo; 1981 Aug; (8):81-3. PubMed ID: 7269517
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhalation of cycloserine in the complex therapy of patients with pulmonary tuberculosis].
    Kulik NM
    Probl Tuberk; 1967; 45(5):38-40. PubMed ID: 5617943
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of a new vitamin B triad active by oral route].
    Calemard E; Imbert P
    Lyon Med; 1966 Jul; 216(27):25-9. PubMed ID: 5946060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods].
    Smirnov GA; Valiev RSh
    Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis.
    Roth DE; Soto G; Arenas F; Bautista CT; Ortiz J; Rodriguez R; Cabrera L; Gilman RH
    J Infect Dis; 2004 Sep; 190(5):920-7. PubMed ID: 15295697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment.
    Zea AH; Culotta KS; Ali J; Mason C; Park HJ; Zabaleta J; Garcia LF; Ochoa AC
    J Infect Dis; 2006 Nov; 194(10):1385-93. PubMed ID: 17054067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extra-pulmonary and pulmonary tuberculosis in Hong Kong.
    Noertjojo K; Tam CM; Chan SL; Chan-Yeung MM
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):879-86. PubMed ID: 12365574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients.
    Seyedrezazadeh E; Ostadrahimi A; Mahboob S; Assadi Y; Ghaemmagami J; Pourmogaddam M
    Respirology; 2008 Mar; 13(2):294-8. PubMed ID: 18339032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of destructive pulmonary tuberculosis with the use of endobronchial methods of administration of antitubercular agents].
    Rzhavskov IuV
    Probl Tuberk; 1966; 44(4):16-21. PubMed ID: 5997391
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of vitamin E on serum concentrations of sulfhydryl groups in patients with pulmonary tuberculosis].
    Sushkin AG
    Probl Tuberk; 1983 Jun; (6):41-4. PubMed ID: 6878219
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum calcium during chemotherapy for active pulmonary tuberculosis.
    Kitrou MP; Phytou-Pallikari A; Tzannes SE; Virvidakis K; Mountokalakis TD
    Eur J Respir Dis; 1983 Jul; 64(5):347-54. PubMed ID: 6884447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.